{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:42:24Z","timestamp":1789584144226,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.adro.2018.04.009","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T02:50:35Z","timestamp":1525747835000},"page":"339-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Late toxicity after post-prostatectomy intensity modulated radiation therapy: Evaluating normal-tissue sparing guidelines"],"prefix":"10.1016","volume":"3","author":[{"given":"Adil S.","family":"Akthar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash D.","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina H.","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Pelizzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley L.","family":"Liauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2018.04.009_bib0010","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.juro.2008.11.032","article-title":"Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term followup of a randomized clinical trial","volume":"181","author":"Thompson","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.adro.2018.04.009_bib0015","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","article-title":"Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: Long-term results of a randomised controlled trial (EORTC trial 22911)","volume":"380","author":"Bolla","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2018.04.009_bib0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2014.03.011","article-title":"Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02\/AUO AP 09\/95 trial","volume":"66","author":"Wiegel","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2018.04.009_bib0025","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1001\/jama.299.23.2760","article-title":"Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy","volume":"299","author":"Trock","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.adro.2018.04.009_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijrobp.2015.10.048","article-title":"Report of NRG Oncology\/RTOG 9601, A phase 3 trial in prostate cancer: Anti-androgen therapy (AAT) with bicalutamide during and after radiation therapy (RT) in patients following radical prostatectomy (RP) with pT2-3pN0 disease and an elevated PSA","volume":"94","author":"Shipley","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.04.009_bib0035","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/annonc\/mdw604","article-title":"Causes of death among cancer patients","volume":"28","author":"Zaorsky","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.adro.2018.04.009_bib0040","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1001\/jama.296.19.2329","article-title":"Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial","volume":"296","author":"Thompson","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.adro.2018.04.009_bib0045","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.juro.2015.03.122","article-title":"Low use of immediate and delayed postoperative radiation for prostate cancer with adverse pathological features","volume":"194","author":"Maurice","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.adro.2018.04.009_bib0050","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.clgc.2014.12.005","article-title":"National trends in the recommendation of radiotherapy after prostatectomy for prostate cancer before and after the reporting of a survival benefit in March 2009","volume":"13","author":"Mahal","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.adro.2018.04.009_bib0055","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.eururo.2015.04.003","article-title":"Declining use of radiotherapy for adverse features after radical prostatectomy: Results from the National Cancer Data Base","volume":"68","author":"Sineshaw","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2018.04.009_bib0060","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s13566-014-0172-5","article-title":"Adoption of Radiation Therapy Oncology Group consensus guidelines for post-prostatectomy radiation therapy in an academic tertiary care center","volume":"3","author":"Marcus","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2018.04.009_bib0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijrobp.2013.10.042","article-title":"Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer","volume":"88","author":"Ghadjar","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.04.009_bib0070","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.adro.2016.10.002","article-title":"ACR Appropriateness Criteria\u00ae external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II","volume":"2","author":"Zaorsky","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2018.04.009_bib0075","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ijrobp.2007.04.068","article-title":"Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy","volume":"69","author":"Wiltshire","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.04.009_bib0080","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic normal tissue contouring guidelines for radiation therapy: A Radiation Therapy Oncology Group consensus panel atlas","volume":"83","author":"Gay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.04.009_bib0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijrobp.2010.09.058","article-title":"Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity","volume":"82","author":"Pederson","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.04.009_bib0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.prro.2012.08.004","article-title":"Late toxicity after intensity modulated and image guided radiation therapy for localized prostate cancer and post-prostatectomy patients","volume":"3","author":"Hunter","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2018.04.009_bib0095","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijrobp.2009.08.023","article-title":"Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer","volume":"78","author":"Nath","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.04.009_bib0100","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.eururo.2011.08.006","article-title":"Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy","volume":"60","author":"Goenka","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2018.04.009_bib0105","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1016\/j.prro.2015.02.015","article-title":"Phase 2 trial of guideline-based postoperative image guided intensity modulated radiation therapy for prostate cancer: Toxicity, biochemical, and patient-reported health-related quality-of-life outcomes","volume":"5","author":"Berlin","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2018.04.009_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141639","article-title":"Quality of life after post-prostatectomy intensity modulated radiation therapy: Pelvic nodal irradiation is not associated with worse bladder, bowel, or sexual outcomes","volume":"10","author":"Melotek","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.adro.2018.04.009_bib0115","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.prro.2015.12.004","article-title":"Bladder dose-volume parameters are associated with urinary incontinence after postoperative intensity modulated radiation therapy for prostate cancer","volume":"6","author":"Son","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2018.04.009_bib0120","first-page":"8535","article-title":"Patient reported outcomes among treatment modalities for prostate cancer","volume":"23","author":"Johnson","year":"2016","journal-title":"Can J Urol"},{"key":"10.1016\/j.adro.2018.04.009_bib0125","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ejca.2011.08.013","article-title":"Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling","volume":"48","author":"Ohri","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2018.04.009_bib0130","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0360-3016(02)04117-2","article-title":"Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2\u2009Gy)","volume":"55","author":"Cozzarini","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.04.009_bib0135","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1200\/JCO.2015.63.3529","article-title":"Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: First results of the randomized trial SAKK 09\/10","volume":"33","author":"Ghadjar","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2018.04.009_bib0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.clon.2007.01.001","article-title":"RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery)","volume":"19","author":"Parker","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.adro.2018.04.009_bib0145","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.eururo.2008.06.048","article-title":"Characteristics of spontaneous activity in the bladder trigone","volume":"56","author":"Roosen","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2018.04.009_bib0150","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0360-3016(94)00431-J","article-title":"The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy","volume":"31","author":"Marks","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.04.009_bib0155","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ijrobp.2009.02.026","article-title":"External beam radiotherapy for prostate cancer patients on anticoagulation therapy: How significant is the bleeding toxicity?","volume":"76","author":"Choe","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2018.04.009_bib0160","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.28128","article-title":"Tobacco use and external beam radiation therapy for prostate cancer: Influence on biochemical control and late toxicity","volume":"119","author":"Solanki","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2018.04.009_bib0165","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/sj.bjc.6600266","article-title":"Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma","volume":"86","author":"Sanguineti","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.adro.2018.04.009_bib0170","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1470-2045(16)00111-X","article-title":"Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): A randomised, multicentre, open-label phase 3 trial","volume":"17","author":"Carrie","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2018.04.009_bib0175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5489\/cuaj.1764","article-title":"Long-term complications in men who have early or late radiotherapy after radical prostatectomy","volume":"8","author":"Sowerby","year":"2014","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.adro.2018.04.009_bib0180","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.pcan.4500718","article-title":"External beam radiation therapy after radical prostatectomy: Efficacy and impact on urinary continence","volume":"7","author":"Petroski","year":"2004","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.adro.2018.04.009_bib0185","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.eururo.2013.01.027","article-title":"Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy","volume":"65","author":"Suardi","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2018.04.009_bib0190","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.urology.2013.01.047","article-title":"Toxicity after external beam radiotherapy for prostate cancer: An analysis of late morbidity in men with diabetes mellitus","volume":"81","author":"Kalakota","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.adro.2018.04.009_bib0195","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.clgc.2016.08.020","article-title":"Prostate cancer patients with unmanaged diabetes or receiving insulin experience inferior outcomes and toxicities after treatment with radiation therapy","volume":"15","author":"Zaorsky","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.adro.2018.04.009_bib0200","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.juro.2006.06.002","article-title":"Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer","volume":"176","author":"Zelefsky","year":"2006","journal-title":"J Urol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109418300721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109418300721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:35:45Z","timestamp":1762529745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109418300721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2452109418300721"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2018.04.009","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late toxicity after post-prostatectomy intensity modulated radiation therapy: Evaluating normal-tissue sparing guidelines","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2018.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}